News
1h
Zacks Investment Research on MSNSlowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in US infants.
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
22h
MedPage Today on MSNRemoved ACIP Members Say 'U.S. Vaccine Program Critically Weakened'Joining ACIP involves a rigorous process, they argued, including submitting letters of support from experts and peers, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results